Although estimates show that at the time of authorization comparative efficacy data are available for 50 percent to 70 percent of new drugs are available, the researchers say that it varies in therapeutic areas and only a small %age of the evidence is often the the time available the marketing authorization.
In essence, a heavy a heavy metal stuck on DNA, you can get a mutation, Stearns says. Other heavy metals are known to bind to the DNA, but Stearns and her colleagues are the first this characteristic this characteristic with uranium. The findings were recently Mutagenesis Mutagenesis and Molecular Carcinogenesis. Continue reading